Invesco
INFI

Invesco’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Invesco’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-31,078
Closed -$35K – 4189
2022
Q1 		$35K Sell
31,078
-58
-0.2% -$69 ﹤0.01% 3955
2021
Q4 		$70K Buy
31,136
+304
+1% +$763 ﹤0.01% 3944
2021
Q3 		$105K Buy
30,832
+7,448
+32% +$23K ﹤0.01% 3933
2021
Q2 		$70K Buy
+23,384
New +$74K ﹤0.01% 3930
2019
Q1 		– Sell
-12,955
Closed -$15K – 3864
2018
Q4 		$15K Sell
12,955
-546
-4% -$982 ﹤0.01% 3769
2018
Q3 		$37K Sell
13,501
-2,043
-13% -$4.23K ﹤0.01% 3830
2018
Q2 		$30K Buy
+15,544
New +$31.4K ﹤0.01% 3819
2017
Q1 		– Sell
-32,543
Closed -$44K – 3766
2016
Q4 		$44K Buy
32,543
+518
+2% +$677 ﹤0.01% 3665
2016
Q3 		$50K Buy
32,025
+5,267
+20% +$8.09K ﹤0.01% 3628
2016
Q2 		$36K Buy
26,758
+2,219
+9% +$10.4K ﹤0.01% 3674
2016
Q1 		$129K Buy
+24,539
New +$150K ﹤0.01% 3629
2015
Q3 		– Sell
-368,812
Closed -$4.04M – 4048
2015
Q2 		$4.04M Sell
368,812
-1,115,510
-75% -$14.3M ﹤0.01% 2162
2015
Q1 		$20.8M Buy
1,484,322
+1,068,054
+257% +$16.3M 0.01% 1176
2014
Q4 		$7.03M Buy
416,268
+326,846
+366% +$4.76M ﹤0.01% 1698
2014
Q3 		$1.2M Sell
89,422
-29,117
-25% -$347K ﹤0.01% 2857
2014
Q2 		$1.51M Sell
118,539
-2,526
-2% -$26.3K ﹤0.01% 2759
2014
Q1 		$1.44M Buy
121,065
+16,214
+15% +$218K ﹤0.01% 2795
2013
Q4 		$1.45M Sell
104,851
-217,806
-68% -$3.08M ﹤0.01% 2870
2013
Q3 		$5.62M Buy
322,657
+74,255
+30% +$1.42M ﹤0.01% 1838
2013
Q2 		$4.02M Buy
+248,402
New +$7.69M ﹤0.01% 1968

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Invesco's INFI Position: Q2 2022 in Review

Invesco sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 31,078 shares — an estimated $35K sold.

Invesco first reported a position in INFI in Q2 2013 and held it in 20 quarters. The position peaked at $20.8M in Q1 2015. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Invesco reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 31,078 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $35K.
  • Invesco first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Invesco's Infinity Pharmaceuticals, Inc. position peaked at $20.8M in Q1 2015.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.